Thermo Fisher Scientific

Market Cap (Mar-08-2026)

186.474 Billion USD

World Rank (Jan-05-2024)

52

Market Cap (Jan-05-2024)

207.621 Billion USD

World Rank (Jul-30-2023)

48

Market Cap (Jul-30-2023)

216.720 Billion USD

World Rank (Jan-07-2022)

45

Market Cap (Jan-07-2022)

239.220 Billion USD

World Rank (Jan-01-2021)

54

Market Cap (Jan-01-2021)

184.600 Billion USD

Company Rank in Country in 2023

Rank in USA in July-2023 is 30

Headquarters Country

USA

Nasdaq / NYSE Code

TMO

CEO

Marc N. Casper

Founders

George N. Hatsopoulos

Employee Count

130,000

Employee Count as of Date

As on Dec-2022

Headquarters City/State

Massachusetts

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

44,556 Million USD

Annual Operating Income in USD

7,746 Million USD

Annual Net Income in USD

6,704 Million USD

Annual Results for Period Ending

Dec-2025 ending year

Total Assets in USD

110,343 Million USD

Total Liabilities in USD

56,806 Million USD

Total Equity in USD

53,537 Million USD

Balance Sheet for Period Ending

Dec-2025 ending year

Business Sector

Healthcare

Medical Equipment / Instruments

Pharmaceutical

Technology Hardware and Instruments

Electronics

Company Website

THERMO FISHER SCIENTIFIC INC

Wikipedia

Yahoo

Yahoo @ NYSE

Facebook

Company Profile

Thermo Fisher Scientific is USA Based Bio-Technology and Healthcare Company. Develops and manufactures Medical Equipment. Headquarters is in USA.

Facts About Company

As on 2022, Thermo Fisher Scientific has 130,000 employees.

Thermo Fisher Scientific annual revenue generated for period ending Dec-2022 was 44,915 million USD.

Thermo Fisher Scientific annual net income generated for period ending Dec-2022 was 6,950 million USD.

For Year ending December-2021, Thermo Fisher Scientific annual revenues was 39,211 Million USD and Net Income was 7,725 Million USD.

As of December-2020, they had 80,000 employees.

Annual Results Summary

Thermo Fisher Scientific Inc - Yearly Revenue and Net Profit - in Million USD:

Fiscal Year	Fiscal Year End	Total Annual Revenue (USD mm)	Gross Profit (USD mm)	Operating Profit (USD mm)	Net Income (USD mm)	Revenue YoY	Gross Margin	Operating Margin	Net Margin
2025	2025-12-31	44,556	18,238	7,746	6,704	3.9%	40.9%	17.4%	15.0%
2024	2024-12-31	42,879	17,702	7,337	6,335	0.1%	41.3%	17.1%	14.8%
2023	2023-12-31	42,857	17,100	6,859	5,995	(4.6%)	39.9%	16.0%	14.0%
2022	2022-12-31	44,915	18,971	8,393	6,950	14.5%	42.2%	18.7%	15.5%
2021	2021-12-31	39,211	19,638	10,028	7,725	21.7%	50.1%	25.6%	19.7%
2020	2020-12-31	32,218	16,004	7,794	6,375	26.1%	49.7%	24.2%	19.8%
2019	2019-12-31	25,542	11,328	4,594	3,696	4.9%	44.4%	18.0%	14.5%
2018	2018-12-31	24,358	10,857	3,779	2,938	16.4%	44.6%	15.5%	12.1%
2017	2017-12-31	20,918	9,448	2,966	2,225	14.5%	45.2%	14.2%	10.6%
2016	2016-12-31	18,274	8,372	2,450	2,022	-	45.8%	13.4%	11.1%

Balance Sheet Summary

Thermo Fisher Scientific Inc - Balance Sheet Summary - in Million USD:

Fiscal Year	Total Assets (USD million)	Total Liabilities (USD million)	Total Equity (USD million)
2025	110,343	56,928	53,415
2024	97,321	47,770	49,551
2023	98,726	52,002	46,724
2022	97,154	53,122	44,032
2021	95,123	54,268	40,855
2020	69,052	34,535	34,517
2019	58,381	28,697	29,684
2018	56,232	28,638	27,594
2017	56,669	31,256	25,413
2016	45,908	24,368	21,540

Founded Year

2006

Institutional Investors

Top 30 Institutional Investors in THERMO FISHER SCIENTIFIC as on MAR-31-2023

RANK	Institutional Investors	DATE	SHARES HELD	CHANGE (SHARES)	CHANGE (%)	VALUE (IN 1,000S)
1	VANGUARD GROUP INC	3/31/2023	32,593,874	59,198	0.18%	$17,847,754
2	BLACKROCK INC.	3/31/2023	31,423,285	633,163	2.06%	$17,206,762
3	STATE STREET CORP	3/31/2023	16,061,498	-223,763	-1.37%	$8,794,955
4	CAPITAL WORLD INVESTORS	3/31/2023	12,924,464	-620,777	-4.58%	$7,077,178
5	MORGAN STANLEY	3/31/2023	11,588,545	-141,518	-1.21%	$6,345,655
6	FMR LLC	3/31/2023	11,354,044	194,602	1.74%	$6,217,247
7	PRICE T ROWE ASSOCIATES INC /MD/	3/31/2023	8,586,632	-537,025	-5.89%	$4,701,868
8	GEODE CAPITAL MANAGEMENT, LLC	3/31/2023	6,985,584	106,233	1.54%	$3,825,166
9	MASSACHUSETTS FINANCIAL SERVICES CO /MA/	6/30/2023	6,794,864	-1,337,890	-16.45%	$3,720,732
10	CAPITAL RESEARCH GLOBAL INVESTORS	3/31/2023	5,933,813	-1,224,453	-17.11%	$3,249,237
11	NORGES BANK	12/31/2022	5,639,611	539,113	10.57%	$3,088,138
12	BANK OF AMERICA CORP /DE/	3/31/2023	5,539,035	-589,829	-9.62%	$3,033,065
13	JPMORGAN CHASE & CO	3/31/2023	5,380,918	202,442	3.91%	$2,946,483
14	NORTHERN TRUST CORP	3/31/2023	4,089,069	21,122	0.52%	$2,239,092
15	PRIMECAP MANAGEMENT CO/CA/	3/31/2023	3,564,109	-94,465	-2.58%	$1,951,635
16	BANK OF NEW YORK MELLON CORP	6/30/2023	3,197,519	-150,520	-4.50%	$1,750,897
17	ARTHUR M. COHEN & ASSOCIATES, LLC	6/30/2023	3,124,051	3,113,975	30904.87%	$1,710,668
18	ROYAL BANK OF CANADA	3/31/2023	2,897,076	212,706	7.92%	$1,586,381
19	WELLINGTON MANAGEMENT GROUP LLP	3/31/2023	2,890,116	-43,755	-1.49%	$1,582,570
20	AMUNDI	3/31/2023	2,816,914	-313,372	-10.01%	$1,542,486
21	PICTET ASSET MANAGEMENT SA	3/31/2023	2,722,523	-2,144	-0.08%	$1,490,799
22	LEGAL & GENERAL GROUP PLC	3/31/2023	2,559,306	32,431	1.28%	$1,401,425
23	FISHER ASSET MANAGEMENT, LLC	6/30/2023	2,457,187	61,347	2.56%	$1,345,506
24	T. ROWE PRICE INVESTMENT MANAGEMENT, INC.	3/31/2023	2,385,884	-51,400	-2.11%	$1,306,462
25	POLEN CAPITAL MANAGEMENT LLC	3/31/2023	2,270,936	77,225	3.52%	$1,243,519
26	MANUFACTURERS LIFE INSURANCE COMPANY, THE	3/31/2023	2,242,164	94,913	4.42%	$1,227,764
27	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	3/31/2023	2,191,596	38,612	1.79%	$1,200,074
28	UBS GROUP AG	3/31/2023	2,070,241	187,629	9.97%	$1,133,623
29	BROWN ADVISORY INC	6/30/2023	2,054,231	34,200	1.69%	$1,124,856
30	FRANKLIN RESOURCES INC	3/31/2023	2,002,011	-10,471	-0.52%	$1,096,261